10x Genomics Inc (TXG) News

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

10x Genomics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

10x Genomics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference PR Newswire PLEASANTON...

Form 3 - Initial statement of beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

10x Genomics Announces Senior Leadership Changes

10x Genomics Announces Senior Leadership Changes PR Newswire PLEASANTON, Calif., Aug. 8, 2024 PLEASANTON...

10x Genomics Reports Second Quarter 2024 Financial Results

10x Genomics Reports Second Quarter 2024 Financial Results PR Newswire PLEASANTON, Calif., Aug. 8, 2024...

10x Genomics Technology Supports TenK10K Project Led by Garvan Institute of Medical Research to Help Transform the Treatment of Complex Diseases

10x Genomics Technology Supports TenK10K Project Led by Garvan Institute of Medical Research to Help Transform...

Form 3 - Initial statement of beneficial ownership of securities

10x Genomics to Report Second Quarter 2024 Financial Results on August 8, 2024

10x Genomics to Report Second Quarter 2024 Financial Results on August 8, 2024 PR Newswire PLEASANTON, Calif...

Form 8-K - Current report

New Insights Into Cleft Palate Unlocked With 10x Genomics' Single Cell and Spatial Technologies

New Insights Into Cleft Palate Unlocked With 10x Genomics' Single Cell and Spatial Technologies PR...